Ian Robert Burton Hudson is a British physician and former government official who served as the chief executive of the

Medicines and Healthcare products Regulatory Agency The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are accepta ...

(MHRA) from 2013 to 2019. He later became Senior Advisor, Integrated Development,

Global Health Global health is the health of populations in a worldwide context; it has been defined as "the area of study, research, and practice that places a priority on improving health and achieving equity in health for all people worldwide". Problems th ...

for the

Bill and Melinda Gates Foundation The Gates Foundation is an American private foundation founded by Bill Gates and Melinda French Gates. Based in Seattle, Washington, it was launched in 2000 and is reported to be List of wealthiest charitable foundations, the third largest char ...

. He retired in February 2024. He was appointed an OBE for services to healthcare in the 2020 New Year Honours.

Career

Hudson practised as a paediatrician from 1982 to 1989, and then worked in clinical

research and development Research and development (R&D or R+D), known in some countries as OKB, experiment and design, is the set of innovative activities undertaken by corporations or governments in developing new services or products. R&D constitutes the first stage ...

in the pharmaceutical industry, lately as a vice president of

SmithKline Beecham GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, w ...

, between 1989 and 2001. In 2001 he became director of the licensing division of the then-Medicines Control Agency. He was also the UK delegate to the European Medicines Agency's Committee for Human Medicinal Products, CHMP, (2002-2013), latterly its vice chair and honorary Senior Lecturer in Clinical Pharmacology, William Harvey Research Institute, Queen Mary and Westfield College, university of London (2007-2012). In September 2013 he became chief executive of the

, succeeding Sir Kent Woods. Hudson was also a member of the

European Medicines Agency The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products ...

's management board, a member of the Heads of Medicines Agencies of Europe Management Group and chaired the International Coalition of Medicines Regulatory Authorities between 2016 and 2019. He retired from the MHRA in 2019 and then worked as a senior advisor, Integrated Development, Bill and Melinda Gates Foundation until retiring in February 2024. He was also the Chair of the International Review Panel for clinical trial accreditation, UKCRC Clinical Trials Unit Network, a member of the Centre for Innovation in Regulatory Science scientific advisory board, and a member of the scientific advisory council of TOPRA. He was appointed an OBE in the

2020 New Year Honours The 2020 New Year Honours are appointments by some of the 16 Commonwealth realms to various orders and honours to recognise and reward good works by citizens of those countries. The New Year Honours are awarded as part of the New Year celebratio ...

for services to healthcare.

References

{{DEFAULTSORT:Hudson, Ian 20th-century British medical doctors British government officials Officers of the Order of the British Empire

Career

See also

References